Agopyan Nadia 4
4 · Marker Therapeutics, Inc. · Filed Feb 22, 2022
Insider Transaction Report
Form 4
Agopyan Nadia
VP, Regulatory Affairs
Transactions
- Award
Employee Stock Option (right to buy)
2022-02-17+40,000→ 40,000 totalExercise: $0.46Exp: 2032-02-17→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]This option vests in equal monthly installments over a four year period commencing on March 17, 2022 subject to the continued service by the Reporting Person to the Issuer as of the applicable vesting date.